Pharmacology of metabotropic glutamate receptors

Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology

Volumn , Issue , 2001, Pages 151-186

  Schoepp, Darryle D ^a   Monn, James A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057502930     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (161)

1. 2+ signal transduction’, J. Biol. Chem. 267: 13,361-13,368.
2. Acher, F.C., Tellier, F.J., Azerad, R., Brabet, I.N., Fagni, L. and Pin, J.P. (1997) ‘Synthesis and pharmacological characterisation of aminocyclopentanetricarboxylic acids: New tools to discriminate between metabotropic glutamate receptor subtypes’, J. Med. Chem. 40: 3119-3129.
3. Ahmadian, H., Nielsen, B., Bräuner-Osborne, H., Johansen, T.N., Stensbøl, T.B., Sløk, F.A., Sekiyama, N., Nakanishi, S., Krogsgaard-Larsen, P. and Madsen, U. (1997) '(S)-Homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors’, J. Med. Chem. 40: 3700-3705.
4. Allen, J.W., Ivanova, S.A., Fan, L., Espey, M.G., Basile, A.S. and Faden, A.I. (1999) ‘Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury’, J. Pharmacol. Exp. Ther. 290: 112-128.
5. Annoura, H., Fukunaga, A., Uesugi, M., Tatsuoka, T. and Horikawa, Y. (1996) ‘A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1acarboxylates’, Bioorg. Med. Chem. Lett. 6: 763-766.
6. Anwyl, R. (1999) ‘Metabotropic glutamate receptors: electrophysiological properties and role in plasticity’, Brain Res. Reviews 29: 83-120.
7. Attwell, P.J.E., Kaura, S., Sigala, G., Bradford, H.F., Croucher, M.J., Jane, D.E. and Watkins, J.C. (1995) ‘Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist’, Brain Res. 698: 155-162.
8. Attwell, P.J.E., Koumentaki, A., Croucher, M.J. and Bradford, H.F. (1998) ‘Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats’, Brain Res. 787: 286-291.
9. Baker, S.R., Goldsworthy, J., Harden, R.C., Salhoff, C.R. and Schoepp, D.D. (1995) ‘Enzymatic resolution and pharmacological activity of the enantiomers of 3,5-dihydroxyphenylglycine, a metabotropic glutamate receptor agonist’, Bioorg. Med. Chem. Lett. 5: 223-228.
10. Baker, S.R., Clark, B.P., Harris, J.R., Griffy, K.I., Kingston, A.E. and Tizzano, J.P. (1998) ‘LY393675: an a-substituted-cyclobutylglycine, is a potent group I metabotropic glutamate receptor antagonist’, Soc. Neurosci. Abstr. 24: 576.
11. Battaglia, G., Monn, J.A. and Schoepp, D.D. (1997) ‘In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740', Neurosci. Lett. 229: 161-164.
12. Birse, E.F., Eaton, S.A., Jane, D.E., Jones, P.L.St.J., Porter, R.H.P., Pook, P.C.-K., Sunter, D.C., Udvarhelyi, P.M., Wharton, B., Roberts, P.J., Salt, T.E. and Watkins, J.C. (1993) ‘Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system’, Neuroscience 52: 481-488.
13. Bond, A, O’Neill, M.J., Hicks, C.A., Monn, J.A. and Lodge, D. (1998) ‘Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia’, NeuroReport 9: 1191-1193.
14. Bordi, F. and Ugolini, A. (1999) ‘Group I metabotropic glutamate receptors: implications for brain diseases’, Prog. Neurobiol. 59: 55-79.
15. Bowes, M., Panesar, M., Gentry, C., Urban, L., Gasparini, F., Kuhn, R. and Walker, K. (1999) ‘Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, methylphenylethynylpyridine, in rat models of inflammatory pain’, Br. J. Pharmacol. 126 (suppl.): P154.
16. Boyd, E.A., Alexander, S.P.H., Kendall, D.A. and Loh, Jr. V.M. (1996) ‘DHPMP: a novel group I specific metabotropic glutamate receptor agonist’, Bioorg. Med. Chem. Lett. 6: 2137-2140.
17. Brabet, I, Mary, S., Bockaert, J. and Pin, J.-P. (1995) ‘Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses’, Neuropharmacology 34: 895-903.
18. Brabet, I., Parmentier, M.-L., De Colle, C., Bockaert, J., Acher, F. and Pin, J.-P. (1998) ‘Comparative effect of L-CCG-I, DCG-IV and -y-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes’, Neuropharmacology 37: 1043-1051.
19. Bräuner-Osborne, H, Sløk, F.A., Skjærbæk, N., Ebert, B., Sekiyama, N., Nakanishi, S. and Krogsgaard-Larsen, P. (1996) ‘A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid’, J. Med. Chem. 39: 3188-3194.
20. Bräuner-Osborne, H. and Krogsgaard-Larsen, P. (1998) ‘Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphonopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors’, Br. J. Pharmacol. 123: 269-274.
21. Bedingfield, J.S., Jane, D.E., Kemp, M.C., Toms, N.J. and Roberts, P.J. (1996) ‘Novel potent selective phenylglycine antagonists of metabotropic glutamate receptors’, Eur. J. Pharmacol. 309: 71-78.
22. Breakwell, N.A., Huang, L.-Q., Rowan, M.J. and Anwyl, R. (1997) ‘DCG-IV inhibits synaptic transmission by activation of NMDA receptors in area CA1 of rat hippocampus’, Eur. J. Pharmacol. 322: 173-178.
23. Bushell, T.J., Jane, D.E., Tse, H.-W., Watkins, J.C., Davies, C.H., Garthwaite, J. and Collingridge, G.L. (1995) ‘Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4', Neuropharmacology 34: 239-241.
24. Bushell, T.J., Jane, D.E., Tse, H.-W., Watkins, J.C., Garthwaite, J. and Collingridge, G.L. (1996) ‘Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices’, Br. J. Pharmacol. 117: 1457-1462.
25. Camon, L., Vives, P., de Vera, N. and Martinez, E. (1998) ‘Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine’, J. Neurosci. 51: 339-348.
26. Cao, C.Q., Evans, R.H., Headley, P.M. and Udvarhelyi, P.M. (1995) ‘A comparison of the effects of selective metabotropic glutamate receptor agonists on synaptically evoked whole cell currents of rat spinal ventral horn neurones in vitro’ British J. Pharmacol. 115: 1469-1474.
27. B antagonists potentiate dorsal root-evoked excitatory synaptic transmission at neonatal rat spinal motoneurones in vitro’, Neuroscience 78: 243-250.
28. 3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes’, Br. J. Pharmacol. 123: 497-504.
29. Cartmell, J., Monn, J.A. and Schoepp, D.D. (1999) ‘The mGlu2/3 receptor agonists, LY354740 and LY379268: selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats’, J. Pharmacol. Exp. Ther. 291: 161-170.
30. 3H]glutamate binding sites’, NeuroReport 4: 311-313.
31. 3H]Glutamate labels the metabotropic excitatory amino acid receptor in rodent brain’, Neurosci. Lett. 113: 78-83.
32. Chapman, A.G., Yip, P.K., Yap, J.S., Quinn, L.P., Tang, E., Harris, J.R. and Meldrum, B.S. (1999) ‘Anticonvulsant actions of LY367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid)', Eur. J. Pharmacol. 368: 17-24.
33. Clark, B.P., Baker, S.R., Goldsworthy, J., Harris, J.R. and Kingston, A.E. (1997) '(+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors’, Bioorg. Med. Chem. Lett. 7: 2777-2780.
34. Clark, B.P., Harris, J.R., Kingston, A.E. and McManus, D. (1998) 'α-substituted phenylglycines as group I metabotropic glutamate receptor antagonists’, XVth European International Symposium on Medicinal Chemistry, Edinburgh, 6-10 September 1998.
35. Collado, I, Ezquerra, J., Mazon, A., Pedregal, C., Yruretagoyena, B., Kingston, A.E., Tomlinson, R., Wright, R.A., Johnson, B.G. and Schoepp, D.D. (1998) '2,3'-disubstituted-2-(2'-carboxycyclopropyl)glycines as potent and selective antagonists of metabotropic glutamate receptors’, Bioorg. Med. Chem. Lett. 8: 2849-2854.
36. Collins, G.G.S. (1982) ‘Some effects of excitatory amino acid receptor antagonists on synaptic transmission in the rat olfactory cortex slice’, Brain Res. 244: 311-318.
37. Conn, P.J. and Pin, J.-P. (1997) ‘Pharmacology and functions of metabotropic glutamate receptors’, Annu. Rev. Pharmacol. Toxicol. 37: 205-237.
38. Desai, M.A. and Conn P.J. (1990) ‘Selective activation of phosphoinositide hydrolysis by a rigid analogue of glutamate’, Neurosci. Lett. 109: 157-162.
39. Desai, M.A., Burnett, J.P., Mayne, N.G. and Schoepp, D.D. (1995) ‘Cloning and expression of a human metabotropic glutamate receptor 1α: enhanced coupling on co-transfection with a glutamate transporter’, Mol. Pharmacol. 48: 648-657.
40. Doherty, A.J., Palmer, M.J., Henley, J.M., Collingridge, G.L. and Jane, D.E. (1997) '(RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5: but not mGlu1: receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus’, Neuropharmacol. 36: 265-267.
41. Doherty, A.J., Collingridge, G.L. and Jane, D.E. (1999) ‘Antagonist activity of α-substituted 4-carboxyphenylglycine analogues at group I metabotropic glutamate receptors expressed in CHO cells’, Br. J. Pharmacol. 126: 205-210.
42. Dutar, P., Vu, H.M. and Perkel, D.J. (1999) ‘Pharmacological characterization of an unusual mGluR- evoked neuronal hyperpolarization mediated by activation of GIRK channels’, Neuropharmacology 38: 467-475.
43. Escribano, A., Ezquerra, J., Pedregal, C., Rubio, A., Yruretagoyena, B., Baker, S.R., Wright, R.A., Johnson, B.G. and Schoepp, D.D. (1998) '(2S,4S)-2-amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonist’, Bioorg. Med. Chem. Lett. 8: 765-770.
44. Favaron, M., Manev, R.M., Candeo, P., Arban, R., Gabellini, N., Kozikowski, A.P. and Manev, H. (1993) ‘Trans-azetidine-2,4-dicarboxylic acid activates neuronal metabotropic receptors’, NeuroReport 4: 967-970.
45. Fisher, K. and Coderre, T.J. (1996) ‘Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists’, NeuroReport 7: 2743-2747.
46. Fisher, K. and Coderre, T.J. (1998) ‘Hyperalgesia and allodynia induced by the intrathecal (RS)-dihydroxyphenylglycine in rats’, NeuroReport 9: 1169-1172.
47. Fitzjohn, S.M., Irving, A.J., Palmer, M.J., Harvey, J., Lodge, D. and Collingridge, G.L. (1996) ‘Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices’, Neurosci. Lett. 203: 211-213.
48. Fitzjohn, S.M., Bortolotto, Z.A., Palmer, M.J., Doherty, A.J., Ornstein, P.L., Schoepp, D.D., Kingston, A.E., Lodge, D. and Collingridge, G.L. (1998) ‘The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity’, Neuropharmacology 37: 1445-1458.
49. Fotuhi, M., Sharp, A.H., Glatt, C.E., Hwang, P.M., von Krosigk, M., Synder, S.H. and Dawson, T.M. (1993) ‘Differential localization of phosphoinositide-linked metabotropic glutamate receptor (mGluR1) and inositol 1,4,5-trisphosphate receptor in rat brain’, J. Neurosci. 13: 2001-2012.
50. Ganong, A.H. and Cotman, C.W. (1982) ‘Acidic amino acid antagonists of lateral perforant path synaptic transmission: agonist-antagonist interactions in the dentate gyrus’, Neurosci. Lett. 34: 195-200.
51. Gasparini, F., Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Sommer, B., Varney, M.A., Hess, S.D., Johnson, E.C., Kuhn, R., Urwyler, S., Sauer, D., Portet, C., Schmutz, M., Nicoletti, F. and Flor, P.J. (1999a) '(R, S)-4-phosphonophenyglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsant and neuroprotective in vivo’, J. Pharmacol. Exp. Ther. 290: 1678-1687.
52. Gasparini, F., Lingenhoehl, K., Flor, P.J., Munier, N., Heinrich, M., Vranesic, I., Biollaz, M., Heckendorn, R., Allgeier, H., Varney, M., Johnson, E., Hess, S.D., Veliçelebi, G. and Kuhn, R. (1999b) ‘Methylphenylethynylpyridine (MPEP): a novel potent, subtype-selective and systemically active antagonist at metabotropic glutamate receptor subtype 5', Br. J. Pharmacol. 126(suppl): P154.
53. Gereau, R.W. and Conn, J.P. (1995) ‘Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability’, J. Neurophysiology 74: 122-129.
54. Gomeza, J., Mary, S., Brabet, I., Parmentier, M.-L., Restituito, S., Bockaert, J. and Pin, J.-P. (1996) ‘Coupling of metabotropic glutamate receptors 2 and 4 to Gα15: Gα16: and chimeric Gαq/i proteins: characterization of new antagonists’, Mol. Pharmacol. 50: 923-930.
55. Han, G. and Hampson, D.R. (1999) ‘Ligand binding of the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor’, J. Biol. Chem. 274: 10,008-10,013.
56. Hayashi, Y., Tanabe, Y., Aramori, I., Masu, M., Shimamoto, K., Ohfune, Y. and Nakanishi, S. (1992) ‘Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells’, Br. J. Pharmacol. 107: 539-543.
57. Hayashi, Y., Momiyama, A., Takahashi, T., Ohishi, H., Ogawa-Meguro, R., Shigemoto, R., Mizuno, N. and Nakanishi, S. (1993) ‘Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb’, Nature 366: 687-690.
58. Hayashi, Y., Sekiyama, N., Nakanishi, S., Jane, D.E., Sunter, D.C., Birse, E.F., Udvarhelyi, P.M. and Watkins, J.C. (1994) ‘Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor sub-types’, J. Neurosci. 14: 3370-3377.
59. Helton, D.R., Tizzano, J.P., Monn, J.A., Schoepp, D.D. and Kallman, M.J. (1997) ‘LY354740: A potent, orally active, highly selective metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal’, Neuropharmacology 36: 1511-1516.
60. Helton, D.R., Tizzano, J.P., Monn, J.A., Schoepp, D.D. and Kallman, M.J. (1998a) ‘Anxiolytic and side-effect profile of LY354740: A potent, highly selective, orally active agonist for group II metabotropic glutamate receptors’, J. Pharmacol. Exp. Ther. 284: 651-660.
61. Helton, D.R., Schoepp, D.D., Monn, J.A., Tizzano, J.P. and Kallman, M.J., (1998b) ‘A role for metabotropic glutamate receptors in drug withdrawal states’, in F. Moroni, F. Nicoletti and D.E. Pellegrini-Giampietro, (eds) Metabotropic Glutamate Receptors and Brain Function, London: Portland Press Ltd, pp. 305-314.
62. Hermans, E., Nahorski, S.R. and Chaliss, R.A.J. (1998) ‘Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1a metabotropic glutamate receptor’, Neuropharmacology 37: 1645-1647.
63. 2+ mobilization in rat cerebellar neurons’, Eur. J. Pharmacol. 186: 363-365.
64. Ishida, M., Saitoh, T., Nakamura, Y., Kataoka, K. and Shinozaki, H. (1994) ‘A novel metabotropic glutamate receptor agonist: (2S,1‘S,2‘R,3‘R)-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine (cis-MCG-I)', Eur. J. Pharmacol. Mol. Pharmacol. 268: 267-270.
65. Ishida, M., Saitoh, T., Tsuji, K., Nakamura, Y., Kataoka, K. and Shinozaki, H. (1995) Novel agonists for metabotropic glutamate receptors: trans- and cis-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine (trans- and cis-MCG-I)', Neuropharmacol. 34: 821-827.
66. Ito, I., Kohda, A., Tanabe, S., Hirose, E., Hayashi, M., Mitsunaga, S. and Sugiyama, H. (1992) '3,5-dihydroxyphenylglycine: a potent agonist of metabotropic glutamate receptors’, NeuroReport 3: 1013-1016.
67. Jane, D.E., Jones, P.L.St.J., Pook, P.C.-K., Salt, T.E., Sunter, D.C. and Watkins, J.C. (1993) ‘Stereospecific antagonism by (+)-α-methyl-4-carboxyphenylglycine (MCPG) of (1S,3R)-ACPD- induced effects in neonatal rat motoneurones and rat thalamic neurones’, Neuropharmacology 32: 725-727.
68. Jane, D.E., Jones, P.L.St.J., Pook, P.C.-K., Tse, H.-W. and Watkins, J.C. (1994) ‘Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord’, Br. J. Pharmacol. 112: 809-816.
69. Jane, D.E., Pittaway, K., Sunter, D.C., Thomas, N.K. and Watkins, J.C. (1995) ‘New phenylglycine derivatives with potent and selective antagonist activity at presynaptic glutamate receptors in neonatal rat spinal cord’, Neuropharmacology 34: 851-856.
70. Jane, D.E., Pittaway, K., Sunter, D.C., Thomas, N.K. and Tse, H.-W. (1996) ‘Phosphono substituted amino acids as selective metabotropic glutamate receptor antagonists’, Phosphorus, Sulphur, Silicon and Related Elements 109-110: 313-316.
71. Johansen, P.A., Chase, L.A., Sinor, A.D., Koerner, J.F., Johnson, R.L. and Robinson, M.B. (1995) ‘Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats’, Mol. Pharmacol. 48: 140-149.
72. Johansen, P.A. and Robinson, M.B. (1995) ‘Identification of 2-amino-2-methyl-4-phosphonobutanoic acid as an antagonist at the mGlu(4a) receptor’, Eur. J. Pharmacol. Mol. Pharmacol. 290: R1-R3.
73. 3H]-LY341495 as a novel rapid filtration antagonist radioligand for group II metabotropic glutamate receptors: Characterization of binding to membranes of mGlu receptor subtype expressing cells’, Neuropharmacology 38: 1519-1529.
74. Kemp, M.C., Roberts, P.J., Pook, P.C.-K., Jane, D.E., Jones, A.W., Jones, P.L.St.J., Sunter, D.C., Udvarhelyi, P.M. and Watkins, J.C. (1994) ‘Antagonism of presynaptically mediated depressant responses and cyclic AMP-coupled metabotropic glutamate receptors’, Eur. J. Pharmacol. Mol. Pharmacol. 266: 187-192.
75. Kemp, M.C, Jane, D.E., Tse, H.-W. and Roberts, P.J. (1996) ‘Agonists of cyclic AMP-coupled metabotropic glutamate receptors in adult-rat cortical slices’, Eur. J. Pharmacol. 309: 79-85.
76. Kingston, A.E., Ornstein, P.L., Wright, R.A., Johnson, B.G., Mayne, N.G., Burnett, J.P., Belagaje, R., Wu, S. and Schoepp, D.D. (1998) ‘LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors’, Neuropharmacology 37: 1-12.
77. Klein, J., Reymann, K.G. and Riedel, G. (1997) ‘Activation of phospholipases C and D by the novel metabotropic glutamate receptor agonist t-ADA’, Neuropharmacology 36: 261-263.
78. Knöpfel, T., Sakaki, J., Flor, P.J., Baumann, P., Sacaan, A.I., Veliçelebi, G., Kuhn, R. and Allgeier, H. (1995a) ‘Profiling of trans-azetidine-2,4-dicarboxylic acid at the human metabotropic glutamate receptors mGlu1b, -2, -4a and -5a’, Eur. J. Pharmacol. 288: 389-392.
79. Knöpfel, T., Lukic, S., Leonardt, T., Flor, P.J., Kuhn, R. and Gasparini, F. (1995b) ‘Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes’, Neuropharmacology 34: 1099-1102.
80. Koerner, J.F. and Cotman, C.W. (1981) ‘Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex’, Brain Res. 216: 192-198.
81. 35S]GTP-γS binding assays’, Soc. Neurosci. Abstr. 24: 576.
82. Kozikowski, A.P., Tückmantel, W., Liao, Y., Manev, H., Ikonomovic, S. and Wroblewski, J.T. (1993) ‘Synthesis and metabotropic receptor activity of the novel rigidified glutamate analogues (+)- and (-)-trans-azetidine-2,4-dicarboxylic acid and their N-methyl derivatives’, J. Med. Chem. 36: 2706-2708.
83. Kozikowski, A.P., Steensma, D., Luca-Araldi, G., Tückmantel, W., Wang, S., Pshenichkin, S., Surina, E. and Wroblewski, J.T. (1998) ‘Synthesis and biology of the conformationally restricted ACPD analog, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist’, J. Med. Chem. 41: 1641-1650.
84. Kroona, H.B., Peterson, N.L., Koerner, J.F. and Johnson, R.L. (1991) ‘Synthesis of the 2-amino-4-phosphonobutanoic acid analogues (E)- and (Z)-2-amino-2,3-methano-4-phosphonobutanoic acid and their evaluation as inhibitors of hippocampal excitatory neurotransmission’, J. Med. Chem. 34: 1692-1699.
85. Lam, A.G.M., Soriano, M.A., Monn, J.A., Schoepp, D.D., Lodge, D. and McCulloch, J. (1998) ‘Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia’, Neurosci. Lett. 254: 121-123.
86. Lanthorn, T.H., Ganong, A.H. and Cotman, C.W. (1984) '2-amino-4-phosphonobutyrate selectively blocks mossy fiber-CA3 responses in guinea pig but not rat hippocampus’, Brain Res. 290: 174-178.
87. Litschig, S., Gasparini, F., Rueegg, D., Stoehr, N., Flor, P.J., Vranesic, I., Prézeau, L., Pin, J.-P., Thomsen, C. and Kuhn, R. (1999) ‘CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding’, Mol. Pharmacol. 55: 453-461.
88. Littman, L., Tokar, C., Venkatraman, S., Roon, R.J., Koerner, J.F., Robinson, M.B. and Johnson, R.L. (1999) ‘Cyclobutane quisqualic acid analogues as selective mGluR5a metabotropic glutamic acid receptor ligands’, J. Med. Chem. 42: 1639-1647.
89. Lujan, R., Nusser, Z., Roberts, J.D.B., Shigemoto, R. and Somogi, P. (1996) ‘Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus’, Eur. J. Neurosci. 8: 1488-1500.
90. Ma, D., Tian, H., Sun, H., Kozikowski, A.P., Pschenichkin, S. and Wroblewski, J.T. (1997) ‘Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists’, Bioorg. Med. Chem. Lett. 9: 1195-1198.
91. 1 receptor antagonist activity’, Neuropharmacology 38: 917-926.
92. Masu, M., Tanabe, Y., Tsuchida, K., Shigemoto, R. and Nakanishi, S. (1991) ‘Sequence and expression of a metabotropic glutamate receptor’, Nature 349: 760-765.
93. Merlin, L.R. and Wong, R.K.S. (1997) ‘Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro’, J. Neurophysiol. 78: 539-544.
94. Moghaddam, B. and Adams, B.W. (1998) ‘Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats’, Science 281: 1349-1352.
95. Monn, J.A., Valli, M.J., Johnson, B.G., Salhoff, C.R., Wright, R.A., Howe, T., Bond, A., Lodge, D., Spangle, L.A., Paschal, J.W., Campbell, J.B., Griffey, K., Tizzano, J.P. and Schoepp, D.D. (1996) ‘Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase’, J. Med. Chem. 39: 2990-3000.
96. Monn, J.A., Valli, M.J., Massey, S.M., Wright, R.A., Salhoff, C.R., Johnson, B.G., Howe, T., Alt, C.A., Rhodes, G.A., Robey, R.L., Griffey, K.R., Tizzano, J.P., Kallman, M.J., Helton, D.R. and Schoepp, D.D. (1997) ‘Design, synthesis and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent, selective and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties’, J. Med. Chem. 40: 528-537.
97. Monn, J.A., Valli, M.J., Massey, S.M., Hansen, M.M., Kress, T.J., Wepsiec, J.P., Harkness, A.R., Grutsch, Jr. J.L., Wright, R.A., Johnson, B.G., Andis, S.L., Kingston, A.E., Tomlinson, R., Lewis, R., Griffey, K.R., Tizzano, J.P. and Schoepp, D.D. (1999) ‘Synthesis, pharmacological characterization and molecular modeling of heterobicyclic amino acids related to LY354740: Identification of LY379268 and LY389795: Two new potent, selective and systemically active agonists for group II metabotropic glutamate receptors’, J. Med. Chem. 42: 1027-1040.
98. Moroni, F., Lombardi, G., Thomsen, C., Leonardi, P., Attucci, S., Peruginelli, F., Torregrossa, S.A., Pellegrini-Giampietro, D.E., Luneia, R. and Pellicciari, R. (1997) ‘Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist’, J. Pharmacol. Exp. Ther. 281: 721-729.
99. 3H]-dicarboxycyclopropyl)glycine binding in rat brain’, J. Neurochem. 71: 2558-2564.
100. Nakagawa, Y., Saitoh, K., Ishihara, T., Ishida, M. and Shinozaki, H. (1990) '(2S,3S,4S)-α-(carboxycyclopropyl)glycine is a novel agonist of metabotropic glutamate receptors’, Eur. J. Pharmacol. 184: 205-206.
101. L-2-amino-4-phosphonobutyrate’, J. Biol. Chem. 268: 11,868-11,873.
102. Nakanishi, S. (1992) ‘Molecular diversity of glutamate receptors and implications for brain function’, Science 258: 597-603.
103. Nicoletti, F., Bruno, V., Copani, A., Casabona, G., Knopfel, T. (1996) ‘Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?', Trends in Neurosci. 19: 267-271.
104. Ohfune, Y., Shimamoto, K., Ishida, M. and Shinozaki, H. (1993) ‘Synthesis of L-2-(2,3-dicarboxycyclopropyl)glycines. Novel conformationally restricted glutamate analogues’, Bioorg. Med. Chem. Lett. 3: 15-18.
105. Okamoto, T., Sekiyama, N., Otsu, M., Shimada, Y., Sato, A., Nakanishi, S. and Jingami, H. (1998) ‘Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1', J. Biol. Chem. 273: 13,089-13,096.
106. Ong, W.Y. and Balcar, V.J. (1997) ‘Group I metabotropic glutamate receptor agonist causes neurodegeneration in rat hippocampus’, J. Brain Res. 3: 317-322.
107. Ornstein, P.L., Bleisch, T.J., Arnold, M.B., Wright, R.A., Johnson, B.G. and Schoepp, D.D. (1998a) '2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution’, J. Med. Chem. 41: 346-357.
108. Ornstein, P.L., Bleisch, T.J., Arnold, M.B., Kennedy, J.H., Wright, R.A., Johnson, B.G., Tizzano, J.P., Helton, D.R., Kallman, M.J., Schoepp, D.D. and Hérin, M. (1998b) '2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability’, J. Med. Chem. 41: 358-378.
109. 3H]LY341495: a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors’, Bioorg. Med. Chem. Lett. 8: 1919-1922.
110. Palmer, E., Monaghan, D.T. and Cotman, C.W. (1989) ‘Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor’, Eur. J. Pharmacol. 166: 585-587.
111. Pellicciari, R., Luneia, R., Constantino, G., Marinozzi, M., Natalini, B., Jakobsen, P., Kanstrup, A., Lombardi, G., Moroni, F. and Thomsen, C. (1995) '1-aminoindan-1,5-dicarboxylic acid: a novel antagonist of phospholipase C-linked metabotropic glutamate receptors’, J. Med. Chem. 38: 3717-3719.
112. Pellicciari, R., Raimondo, M., Marinozzi, M., Natalini, B., Costantino, G. and Thomsen, C. (1996a) '(S)-(+)-2-(3'-carboxybicyclo[1,1,1]pentyl)glycine, a structurally new group I metabotropic glutamate receptor antagonist’, J. Med. Chem. 39: 2874-2876.
113. Pellicciari, R., Marinozzi, M., Natalini, B., Costantino, G., Luneia, R., Giorgi, G., Moroni, F. and Thomsen, C. (1996b) ‘Synthesis and pharmacological characterisation of all sixteen stereoisomers of 2-(2'-carboxy-3'-phenylcyclopropyl)glycine. Focus on (2S,1‘S,2‘S,3‘R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a novel and selective group II metabotropic glutamate receptor antagonist’, J. Med. Chem. 39: 2259-2269.
114. Peterson, N.L., Kroona, H.B., Johnson, R.L. and Koerner, J.F. (1992) ‘Activity of the conformationally rigid 2-amino-4-phosphonobutanoic acid (AP4) analogue (RS)-1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid (cyclobutylene AP5) on evoked responses in the perforant pathway of rat hippocampus’, Brain Res. 571: 162-164.
115. Pin, J.-P. and Bockaert J. (1999) ‘Structure and function of metabotropic glutamate receptors’, in J. Egebjerg, A. Schousboe and P. Krogsgarrd-Larsen, P. (eds) Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology, London: Taylor & Francis, pp. 134-165.
116. Pin, J-P. and Duvoisin, R. (1995) ‘The metabotropic glutamate receptors: structure and functions’, Neuropharmacology 34: 1-26.
117. Pisani, A., Calabresi, P., Centonze, D. and Bernardi, G. (1997) ‘Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones’, Brit. J. Pharmacol. 120: 1007-1014.
118. Pook, P.C.-K., Sunter, D.C., Udvarhelyi, P.M. and Watkins, J.C. (1992) ‘Evidence for pre-synaptic depression of monosynaptic excitation in neonatal rat motoneurons by (1S,3S)-ACPD and (1S,3R)-ACPD’, Experimental Physiology 77: 529-532.
119. Roberts, P.J. (1995) ‘Pharmacological tools for the investigation of metabotropic glutamate receptors (mGluRs): phenylglycine derivatives and other selective antagonists - an update’, Neuropharmacology 34: 813-819.
120. Salt, T.E. and Eaton, S.A. (1995) ‘Distinct presynaptic metabotropic receptors for L-AP4 and CCG1 on GABAergic terminals: pharmacological evidence using novel α-methyl derivative mGluR antagonists, MAP4 and MCCG, in the rat thalamus in vivo’, Neuroscience 65: 5-13.
121. Salt, T.E. and Turner, J.P. (1996) ‘Antagonism of the presumed presynaptic action of L-AP4 on GABAergic transmission in the ventrobasal thalamus by the novel mGluR antagonist MPPG’, Neuropharmacology 35: 239-241.
122. Salt, T.E. and Turner, J.P. (1998) ‘Reduction of sensory and metabotropic glutamate receptor responses in the thalamus by the novel metabotropic glutamate receptor-1-selective antagonist S-2-methyl-4-carboxy-phenylglycine’, Neuroscience 85: 655-658.
123. Saugstad, J.A., Kinzie, J.M., Shinohara, M.M., Segerson, T.P. and Westbrook, G.L. (1997) ‘Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile’, Mol. Pharmacol. 51: 119-125.
124. 3H]LY354740: in rat brain’, Mol. Pharmacol. 53: 228-233.
125. Schoepp, D.D. and Conn, P.J. (1993) ‘Metabotropic glutamate receptors in brain function and pathology’, Trends in Pharmacol. Sci. 14: 13-20.
126. 3H]glutamate receptor binding in membranes’, Neurosci. Lett., 145: 100-104.
127. Schoepp, D.D., Bockaert, J. and Sladeczek, F. (1990) ‘Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors’, Trends Pharmacol. Sci. 11: 508-515.
128. Schoepp, D.D., Johnson, B.G., True, R.A. and Monn, J.A. (1991) ‘Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysis’, Eur. J. Pharmacol. Mol. Pharmacol. 207: 351-353.
129. Schoepp, D.D., Goldsworthy, J., Johnson, B.G., Salhoff, C.R. and Baker, S.R. (1994) '3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus’, J. Neurochem. 63: 769-772.
130. Schoepp, D.D., Johnson, B.G., Salhoff, C.R., Wright, R.A., Goldsworthy, J.S. and Baker, S.R. (1995a) ‘Second-messenger responses in brain slices to elucidate novel glutamate receptors’, J. Neurosci. Methods 59: 105-110.
131. Schoepp, D.D., Johnson, B.G., Salhoff, C.R., Valli, M.J., Desai, M.A., Burnett, J.P., Mayne, N.G. and Monn, J.A. (1995b) ‘Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate’, Neuropharmacology 34: 843-850.
132. Schoepp, D.D., Salhoff, C.R., Wright, R.A., Johnson, B.G., Burnett, J.P, Mayne, N.G., Belagaje, R., Wu, S. and Monn, J.A. (1996) ‘The novel metabotropic glutamate receptor agonist 2R,4R- APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors’, Neuropharmacology 35: 1661-1672.
133. Schoepp, D.D., Johnson, B.G., Wright, R.A., Salhoff, C.R., Mayne, N.G., Wu, S., Cockerham, S.L., Burnett, J.P., Belagaje, R., Bleakman, D. and Monn, J.A. (1997) ‘LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors’, Neuropharmacol. 36: 1-11.
134. Schoepp, D.D., Johnson, B.G., Wright, R.A., Salhoff, C.R. and Monn, J.A. (1998) ‘Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740: a novel group II metabotropic glutamate receptor agonist’, Naunyn-Schmiedeberg’s Arch. Pharm. 358: 175-180.
135. Schoepp, D.D., Jane, D.E. and Monn, J.A. (1999a) ‘Pharmacological agents acting at subtypes of metabotropic glutamate receptors’, Neuropharmacology 38: 1431-1476.
136. Schoepp, D.D., Jane, D.E. and Monn, J.A. (1999b) ‘LY354740: A systemically active mGlu2/mGlu3 receptor agonist’, CNS Drug Reviews 5: 1-13.
137. Shibuya, A., Sato, A. and Taguchi, T. (1998) ‘Preparation of difluoro analogs of CCGs and their pharmacological evaluations’, Bioorg. Med. Chem. Lett. 8: 1979-1984.
138. Shiells, R.A., Falk, G. and Naghshinch, S. (1981) ‘Action of glutamate and aspartate analogs on rod horizontal and bipolar cells’, Nature 294: 592-594.
139. Shimamoto, K. and Ohfune, Y. (1993) ‘Inversion of cis-substituted α-cyclopropyl acyl anion. Stereoselective entry to the synthesis of a potent metabotropic glutamate agonist, (2S,1‘S,2‘S)-2-(carboxycyclopropyl)glycine (L-CCG-I), and its 3'-substituted analogues’, SynLett. N12: 919-920.
140. Thomas, N.K., Jane, D.E., Tse, H.-W. and Watkins, J.C. (1996) ‘a-methyl derivatives of serine-O- phosphate as novel selective competitive metabotropic glutamate receptor antagonists’, Neuropharmacology 35: 637-642.
141. Thomsen, C. (1997) ‘The L-AP4 receptor’, Gen. Pharmac. 29: 151-158.
142. Thomsen, C., Hansen, L. and Suzdak, P.D. (1994a) ‘L-glutamate uptake inhibitors may stimulate phosphoinositide hydrolysis in baby hamster kidney cells expressing mGluR1a via heteroexchange with L-glutamate without direct activation of mGluR1a’, J. Neurochem. 63: 2038-2047.
143. Thomsen, C., Boel, E. and Suzdak, P.D. (1994b) ‘Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family’, Eur. J. Pharmacol. Mol. Pharmacol. 267: 77-84.
144. Thomsen, C., Klitgaard, H., Sheardown, M., Jackson, H.C., Eskesen, K., Jacobsen, P., Treppendahl, S. and Suzdak, P.D. (1994c) '(S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR)1a and an agonist of mGlu2: protects against audiogenic seizures in DBA/2 mice’, J. Neurochem. 62: 2492-2495.
145. Thomsen, C., Bruno, V., Nicoletti, F., Marinozzi, M. and Pellicciari, R. (1996) '(2S,1‘S,2‘S,3‘R)-2-2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors’, Mol. Pharmacol. 50: 6-9.
146. Tizzano, J.P., Griffey, K.I. and Schoepp, D.D. (1995a) ‘Induction of protection of limbic seizures in mice by mGluR subtype selective agonists’, Neuropharmacol. 8: 1063-1067.
147. Tizzano, J.P., Griffey, K.I., Valli, M.J., Helton, D.R., Kallman, M.J., Schoepp, D.D. and Monn, J.A. (1995b) ‘Intracerebral injections of metabotropic glutamate receptor agonists can induce or protect against limbic seizures in mice’, Behavioral Pharmacology 6: 633.
148. Toms, N.J., Jane, D.E., Kemp, M.C., Bedingfield, J.S. and Roberts, P.J. (1996) ‘The effects of (RS)-a-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist’, Br. J. Pharmacol. 119: 851-854.
149. Tückmantel, W., Kozikowski, A.P., Wang, S., Pshenichkin, S. and Wroblewski, J.T. (1997) ‘Synthesis, molecular modeling, and biology of the 1-benzyl derivative of APDC - an apparent mGluR6 selective ligand’, Biomed. Chem. Lett. 7: 601-606.
150. Uyama, Y., Ishida, M. and Shinozaki, H. (1997) ‘DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice’, Brain Res. 752: 327-330.
151. Vandergriff, J. and Rasmussen, K. (1999) ‘The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coerulus neurons and behavioral signs of morphine withdrawal’, Neuropharmacology 38: 217-222.
152. Varney, M.A., Cosford, N., Jachec, C., Rao, S.P., Sacaan, A., Lin, F.-F., Bleicher, L., Santori, E.M., Flor, P.J., Allgeier, H., Gasparini, F., Kuhn, R., Hess, S.D., Velicelebi, G. and Johnson, E.C. (1999) ‘SIB-1757 and SIB-1893: Selective, non-competitive antagonists of metabotropic glutamate receptor type 5', J. Pharmacol. Exp. Ther. 290: 170-181.
153. Vignes, M., Clarke, V.R.J., Davies, C.H., Chambers, A., Jane, D.E., Watkins, J.C. and Collingridge, G.L. (1995) ‘Pharmacological evidence for an involvement of group II and group III mGluRs in the presynaptic regulation of excitatory synaptic responses in the CA1 region of rat hippocampal slices’, Neuropharmacology 34: 973-982.
154. Watkins, J.C. (1986) ‘Twenty-five years of excitatory amino acid research’, in P.J. Roberts, J. Storm-Mathisen and H.F. Bradford (eds) Excitatory Amino Acids, London: Macmillan, pp. 1-39.
155. Watkins, J.C. and Collingridge, G.L. (1994) ‘Phenylglycine derivatives as antagonists of metabotropic glutamate receptors’, Trends Pharmacol. Sci. 15: 333-342.
156. Watkins, J.C. and Evans, R.H. (1981) ‘Excitatory amino acid transmitters’, Ann. Rev. Pharmacol. Toxicol. 21: 165-204.
157. Wermuth, C.G., Mann, A., Schoenfelder, A., Wright, R.A., Johnson, B.G., Burnett, J.P., Mayne, N.G. and Schoepp, D.D. (1996) '(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)pentane-1,5-dioic acid: A potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase’, J. Med. Chem. 39: 814-816.
158. Wilsch, V.W., Pidoplichko, V.I., Opitz, T., Shinozaki, H. and Reymann, K.G. (1994) ‘Metabotropic glutamate receptor agonist DCG-IV as NMDA receptor agonist in immature rat hippocampus’, Eur. J. Pharmacol. 262: 287-291.
159. 3H]glutamate binding sites in the rat brain’, J. Neurochem. 63: 938-945.
160. Wu, S., Wright, R.A., Rockey, P.K., Burgett, S.G., Arnold, P.R., Johnson, B.G., Schoepp, D.D. and Belagaje, R. (1998) ‘Group III human metabotropic glutamate receptors 4: 7: and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells’, Mol. Brain Res. 53: 88-97.
161. Yamamoto, C., Sawada, S. and Takada, S. (1983) ‘Suppressing action of 2-amino-4-phosphonobutyric acid on mossy fiber-induced excitation in the guinea pig hippocampus’, Exp. Brain Res. 51: 128-134.